https://scholars.lib.ntu.edu.tw/handle/123456789/473715
標題: | Prognostic implication of MET overexpression in myxofibrosarcomas: An integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis | 作者: | JEN-CHIEH LEE Li C.-F. Fang F.-M. Wang J.-W. YUNG-MING JENG Yu S.C. Lin Y.-T. Wu J.-M. Tsai J.-W. Li S.-H. Huang H.-Y. |
公開日期: | 2010 | 卷: | 23 | 期: | 10 | 起(迄)頁: | 1379-1392 | 來源出版物: | Modern Pathology | 摘要: | It remains obscure in myxofibrosarcoma about the basis of tumorigenesis, progression, and metastasis. Chromosome 7 gains are common in some sarcomas, including myxofibrosarcoma, whereas the specific oncogenes are yet to be characterized. We performed an integrative study of MET gene at 7q31.2 to elucidate its implication in myxofibrosarcoma. Focused on candidate oncogenes on chromosome 7, 385K array comparative genomic hybridization was used to profile DNA copy number alterations of 12 samples. MET transcript was successfully quantified by real-time RT-PCR for 16 laser-microdissected tumors and two myxofibrosarcoma cell lines (NMFH-1, OH931). MET immunoexpression was assessable in 86 primary localized tumors with follow-up. To analyze endogenous MET expression and activation, NMFH-1 and OH931 cells, both with wild-type MET gene, were subjected to Western blotting and hepatocyte growth factor-treated NMFH-1 cells were evaluated for the kinetics of MET tyrosine phosphorylation. Non-random large-scale gains on 7q were detected in five cases, delineating three recurrent amplicons, 7q21.11-7q21.3, 7q22.1-22.3, and 7q31.1-7q32.3, in which the locus of MET displayed increased copy number, among others. MET mRNA was upregulated in OH931, NMFH-1, and nine tumors (56%), whereas neither gene dosage nor mRNA expression of MET was associated with clinicopathological factors. In contrast, MET protein overexpression, present in 67% of cases, was highly related to deep location (P0.004), higher grades (P0.001), and more advanced stages (P0.001). Importantly, MET overexpression independently portended inferior metastasis-free survival (P0.004) and overall survival (P0.0221). Expressing activating phospho-MET at Tyr 1234 /Tyr 1235, OH931 cells had more abundant total MET than NMFH-1 cells, whereas the latter became promptly phosphorylated on stimulation of hepatocyte growth factor. In primary myxofibrosarcomas, MET overexpression, as a frequent event, is likely driven by 7q gains with mRNA upregulation, associated with important prognosticators, and independently predictive of worse outcomes, highlighting its possible causative function in tumor aggressiveness and potentiality as a therapeutic target. ? 2010 USCAP, Inc. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-77957591276&doi=10.1038%2fmodpathol.2010.128&partnerID=40&md5=917ff2ecc9c596a887d19f48dce19561 https://scholars.lib.ntu.edu.tw/handle/123456789/473715 |
ISSN: | 0893-3952 | DOI: | 10.1038/modpathol.2010.128 | SDG/關鍵字: | RNA; scatter factor; adult; aged; amplicon; article; cancer survival; chromosome 7q; comparative genomic hybridization; controlled study; female; fibromyxosarcoma; fibrosarcoma; gene; gene dosage; gene overexpression; human; human tissue; immunoblotting; immunohistochemistry; major clinical study; male; met gene; priority journal; prognosis; protein phosphorylation; real time polymerase chain reaction; tumor localization; Adolescent; Adult; Aged; Aged, 80 and over; Blotting, Western; Chromosomes, Human, Pair 7; Comparative Genomic Hybridization; Female; Fibrosarcoma; Gene Expression Profiling; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Prognosis; Proto-Oncogene Proteins c-met; Receptors, Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Tumor Markers, Biological; Up-Regulation; Young Adult |
顯示於: | 病理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。